Effective treatment of manganese-induced occupational parkinsonism with p-aminosalicylic acid: A case of 17-year follow-up study

Journal of Occupational and Environmental Medicine

Volumn 48, Issue 6, 2006, Pages 644-649

  Jiang, Yue Ming ^a   Mo, Xue An ^a   Du, Feng Qi ^a   Fu, Xue ^a   Zhu, Xia Yan ^a   Gao, Hong Yu ^b   Xie, Jin Lan ^c   Liao, Feng Ling ^b   Pira, Enrico ^d   Zheng, Wei ^e  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Wuzhou Worker's Hospital   (China)

^d UNIVERSITY OF TURIN   (Italy)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; LEVODOPA; MANGANESE; TRIHEXYPHENIDYL;

ADULT; AIRBORNE INFECTION; ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; FOLLOW UP; GAIT; HAND TREMOR; HANDWRITING; HEART PALPITATION; HUMAN; MYOTONIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PROGNOSIS; SAFETY; TIME SERIES ANALYSIS;

DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MANGANESE POISONING; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; P-AMINOSALICYLIC ACID; PARKINSONIAN DISORDERS;

EID: 33745186471     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000204114.01893.3e     Document Type: Article

References (34)

1. Olanow CW. Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci. 2004;1012:209-223.
2. Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed. 2004;17:544-553.
3. Ono K, Komai K, Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J Neurol Sci. 2002;199:93-96.
4. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology. 1999;20:227-238.
5. Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med. 1989;46:856-859.
6. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med. 1993;50:510-513.
7. 1 hyperintensity. Neurology. 2005;64:2033-2039.
8. Lu CS, Huang CC, Chu NS, Calne DB. Levodopa failure in chronic manganism. Neurology. 1994;44:1600-1602.
9. Bleich S, Degner D, Sprung R, Riegel A, Poser W, Rüther E. Chronic manganism: fourteen years of follow-up. J Neuropsychiatry Clin Neurosci. 1999;11:117.
10. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology. 1993;43:1479-1483.
11. Huang CC, Chu NS, Lu CS, Chen RS, Calne DB. Long-term progression in chronic manganism ten years of follow-up. Neurology. 1998;50:698-700.
12. Kessler KR, Wunderlich G, Hefter H, Seitz RJ. Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density. Mov Disord. 2003;18:216-218.
13. Kim YH, Kim JM, Kim JW, et al. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Mov Disord. 2002;17:568-575.
14. Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 2001;56:8-13.
15. Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology. 2005;64:230-235.
16. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology. 1994;44:1583-1586.
17. 2-EDTA chelation. Neurotoxicology. 2000;21:863-866.
18. Ky SQ, Hu WD. Effective observation treatment of chronic manganese poisoning with sodium para-amino salicylate [in Chinese]. Occup Med. 1982;4:8-9.
19. Ky SQ, Deng HS, Xie PY, Hu WD. A report of two cases of chronic serious manganese poisoning treated with sodium para-aminosalicylic acid. Br J Ind Med. 1992;49:66-69.
20. Li Y-T, Ky SQ. Clinical evaluation on treatment of the chronic manganese poisoning with para-amino salicylate [in Chinese]. Ind Health Occup Dis. 1986;6: 363.
21. Fenstermacher J, Kaye T. Drug 'diffusion' within the brain. Ann N Y Acad Sci. 1988;531:29-39.
22. 68Ga]EDTA and positron emission tomography. J Cereb Blood Flow Metab. 1987;7:1-8.
23. Von Holst H, Ericson K, Edner G. Positron emission tomography with 68-Ga-EDTA and computed tomography in patients with subarachnoid hemorrhage. Acta Neurochir. 1989;97:146-149.
24. Aschner M, Vrana KE, Zheng W. Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology. 1999;20:173-180.
25. Dong GQ, Zhang JY. A clinical observation of chronic manganism in welders treated with PAS-Na [in Chinese]. J Occup Health Damage. 2001;16:95-96.
26. Gao XL, Jiang ZH, Liu ZB, Chen J, Yang WC, Wang PA. Compared observation of the therapeutic effect of PAS-Na and EDTA on chronic manganism [in Chinese]. J Labor Med. 2001;18:154-156.
27. Liu ZD, Hider RC. Design of iron chelators with therapeutic application. Coord Chem Rev. 2002;232:151-171.
28. Tandon SK, Chandra SV, Singh J, Husain R, Seth PK. Chelation in metal intoxication. I. In vivo effect of chelating agents on liver and testis of manganese administered rats. Environ Res. 1975;9: 18-25.
29. 2. Toxicology. 1978;9:379-385.
30. Asanuma M, Miyazaki I, Ogawa N. Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases. Curr Pharm Des. 2004;10:695-700.
31. Rothstein JD, Patel S, Regan MR, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433: 73-77.
32. Wu P. A report of one case on the diagnostic treatment with PAS-Na [in Chinese]. Indust Health Occup Dis. 1991;17:163.
33. Zhao DF, Wu S-M. The Clinical Observation on manganism treated with PAS-Na [in Chinese]. J Guiyang Medical College. 1995;20:327-328.
34. Shi X-Y, Zhang J-G. One case on chronic serious mananism treated with sodium para-aminosalicylic acid [in Chinese]. J Baotou Medical College. 2002;18: 161-162.